David James Wilson
Corporate Officer/Principal presso HAEMONETICS CORPORATION
Profilo
David James Wilson is currently the Chief Executive Officer & Director at InnovHeart Srl and the President-Plasma Business Unit at Haemonetics Corp.
He previously worked as the President at Cordis Corp.
from 2015 to 2017 and as the President at Mentor Worldwide LLC.
He also served as the Director at California Healthcare Institute.
Mr. Wilson holds an MBA degree from The Trustees of Columbia University in The City of New York, an undergraduate degree from Auburn University, and a graduate degree from The University of Alabama at Birmingham.
Posizioni attive di David James Wilson
| Società | Posizione | Inizio |
|---|---|---|
| HAEMONETICS CORPORATION | Corporate Officer/Principal | 18/09/2017 |
InnovHeart Srl
 InnovHeart Srl Medical SpecialtiesHealth Technology InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy. | Chief Executive Officer | - |
Precedenti posizioni note di David James Wilson
| Società | Posizione | Fine |
|---|---|---|
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | President | 01/08/2017 |
Mentor Worldwide LLC
 Mentor Worldwide LLC Medical SpecialtiesHealth Technology Mentor Worldwide LLC develops, manufactures and markets science-based products. It offers surgical and non-surgical medical procedures such as breast implants, skin and tissue expanders and facial and dermal implants. The company was founded by Christopher J. Conway in 1969 and is headquartered in Irvine, CA. | President | 01/01/2015 |
| California Healthcare Institute | Director/Board Member | - |
Formazione di David James Wilson
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Auburn University | Undergraduate Degree |
| The University of Alabama at Birmingham | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HAEMONETICS CORPORATION | Health Technology |
| Aziende private | 4 |
|---|---|
Cordis Corp.
Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Health Technology |
Mentor Worldwide LLC
Mentor Worldwide LLC Medical SpecialtiesHealth Technology Mentor Worldwide LLC develops, manufactures and markets science-based products. It offers surgical and non-surgical medical procedures such as breast implants, skin and tissue expanders and facial and dermal implants. The company was founded by Christopher J. Conway in 1969 and is headquartered in Irvine, CA. | Health Technology |
| California Healthcare Institute | Health Technology |
InnovHeart Srl
InnovHeart Srl Medical SpecialtiesHealth Technology InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy. | Health Technology |
- Borsa valori
- Insiders
- David James Wilson
